Categories AlphaGraphs, Earnings, Health Care

Merck’s stock gains after Q4 results beat estimates

Merck’s (MRK) shares climbed over 3% in morning trade on Friday after the company topped revenue and earnings expectations for the fourth quarter of 2018. Worldwide sales grew 5% to $11 billion from the prior-year quarter. Foreign exchange negatively impacted sales by 3%.

Merck fourth quarter 2018 earnings infographic
Merck Q4 2018 Earnings Infographic

On a GAAP basis, the company reported a net income of $1.8 billion or $0.69 per share during the quarter compared to a net loss of $1.04 billion or $0.39 per share in the year-ago period. Last year’s earnings results included a provisional charge related to US tax legislation. On an adjusted basis, net income grew 3% to $2.7 billion while EPS rose 6% to $1.04.

During the quarter, sales in the Pharmaceutical segment grew 6% helped by strength in oncology and vaccines. Sales were negatively impacted by weakness in virology, loss of market exclusivity for certain products and foreign exchange.

Also see: Merck Q4 2018 Earnings Conference Call Transcript

While higher sales of KEYTRUDA and GARDASIL helped fuel growth in oncology and vaccines, a significant drop in ZEPATIER sales due to tough competition and declining patient volumes hurt virology sales.

In Animal Health, sales increased 6%, driven by inline and newly launched products. The growth reflects higher sales of companion animal and livestock products.

The company expects full-year 2019 revenue to be $43.2 billion to $44.7 billion, including a negative impact from foreign exchange of around 1%. GAAP EPS is expected to be $3.97 to $4.12 while adjusted EPS is expected to be $4.57 to $4.72.

 

Get access to timely and accurate verbatim transcripts that are published within hours of the event.

Most Popular

Does Unity Software (U) stock has more room to run?

Last month, the IPO market was in a full swing. IPOs of Snowflake (NYSE: SNOW) and JFROG (NASDAQ: FROG) had an impressive opening day in September, the former creating a

PepsiCo (PEP): Steady snacking habits amid pandemic drive strong quarter for beverage giant

PepsiCo Inc. (NASDAQ: PEP) beat market expectations on both revenue and earnings for the third quarter of 2020. The company saw the momentum continue in its snacks business while the

Does the virus-driven boom make Electronic Arts (EA) a good investment?

With more and more people turning to virtual entertainment sources, amid the virus-related movement restrictions, video game publishers like Electronic Arts (NASDAQ: EA) are witnessing unusually high demand. Not surprisingly,

2 thoughts on “Merck’s stock gains after Q4 results beat estimates

Leave a Reply

Your email address will not be published. Required fields are marked *

Add Comment
Loading...

Cancel
Viewing Highlight
Loading...
Highlight
Close
Top